In that trial, annual NC-AMRI demonstrated a marginally higher sensitivity for HCC detection (71.0%, 22/31) compared to biannual US (45.2%, 14/31), although this difference did not reach statistical significance (P=0.077).
← all excerpts
Comparison of ultrasound-detected and undetected hepatocellular carcinomas: a post-hoc, subgroup analysis from the MAGNUS-HCC surveillance trial.
1
0.0770
0.0770